Lensar (LNSR) Gross Margin Growth (1y) (2020 - 2026)
Lensar (LNSR) Gross Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 60.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -65.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 610.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -359.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn | -279.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -279.00 |
| Dec 31, 2025 | 632.00 |
| Sep 30, 2025 | -335.00 |
| Jun 30, 2025 | -173.00 |
| Mar 31, 2025 | 164,825.00 |
| Dec 31, 2024 | -3,837.00 |
| Sep 30, 2024 | -210.00 |
| Jun 30, 2024 | -363.00 |
| Mar 31, 2024 | -165,028.00 |
| Dec 31, 2023 | -2,265.00 |
| Sep 30, 2023 | -965.00 |
| Jun 30, 2023 | -338.00 |
| Mar 31, 2023 | 212.00 |
| Dec 31, 2022 | 624.00 |
| Sep 30, 2022 | 1,347.00 |
| Jun 30, 2022 | 358.00 |
| Mar 31, 2022 | 332.00 |
| Dec 31, 2021 | 2,745.00 |
| Sep 30, 2021 | -977.00 |
| Jun 30, 2021 | 1,668.00 |